Publication | Closed Access

Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model

Regenerative MedicineNeurodegenerative DiseasesAmyotrophic Lateral SclerosisMedicineSystemic TreatmentNeural Stem CellStem Cell ResearchPathological FeaturesStem-cell TherapyCell TransplantationBiomedical EngineeringMesenchymal Stem CellStem CellsCell BiologyNeuroimmunology